课题基金 / 基金详情

DNA mismatch repair and cancer in murine models

DNA mismatch repair and cancer in murine models
小鼠模型中的 DNA 错配修复和癌症
批准号:
7795082
负责人:
WINFRIED EDELMANN
金额:
$39.47万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 2013-01-31

项目摘要

项目成果

WINFRIED EDELMANN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The DNA mismatch repair (MMR) system is essential for maintaining the integrity of mammalian genomes by removing misincorporated nucleotides that result from erroneous replication and by mediating a DNA damage response after exposure to genotoxic agents. Mutations in mammalian MMR genes result in increased spontaneous mutation rates and strong predisposition to cancer. Eukaryotic MMR is a complex system that requires the interaction of several MutS and MutL proteins for the initiation of the repair reaction. Subsequent to mismatch recognition, downstream events are activated that lead to the excision of misincorporated or damaged nucleotides and the signaling of DNA damage-induced cell cycle arrest and apoptosis. Our research program focuses on elucidating the functions of the individual MutS homologs (Msh) in mammalian MMR and on assessing their importance for the suppression of cancer. In the past funding period, we found that mutations impairing the ATPase activity of the Msh2-Msh6 complex (termed MutS1) cause DNA repair deficiency but do not impair the DNA damage response function of the complex, allowing us to effectively separate these two functions. Our studies further demonstrated that DNA damage signaling by MutS1 is important for the suppression of tumorigenesis in the initial stages of the process. In addition, we demonstrated that MMR missense mutations could result in more heterogeneous cancer phenotypes than those caused by complete loss of function mutations. Based on these results, we hypothesize that both DNA repair and DNA damage signaling by MutS1 contribute to the suppression and tissue specificity of MMR-dependent tumorigenesis. In this continuing application, we plan to investigate this hypothesis by analyzing the contribution of MutS1 to the repair of oxidative DNA damage and assessing the significance of this repair for tumor suppression in MutS1 mutant mice. We will also utilize novel conditional Msh2 mutant mouse models to study the significance of the DNA repair and damage response functions of MutS1 for intestinal tumorigenesis and chemotherapeutic treatment. Finally, we propose to establish an in vivo system to analyze MMR complex formation and identify novel proteins that interact with MutS1 and participate in mismatch excision and DNA damage response in mouse tissues. PUBLIC HEALTH RELEVANCE: The DNA mismatch repair system (MMR) is essential for maintaining the integrity of mammalian genomes and defects in MMR are the cause of the cancer syndrome hereditary nonpolyposis colorectal cancer (HNPCC) and a significant number of sporadic cancers in humans. We are studying mouse lines with mutations in key MMR genes to determine the impact on DNA repair functions, in vivo mutator phenotypes and the ability of MMR to suppress tumor formation. Our studies will provide a better understanding of the biological functions of this important genome maintenance system and of the molecular mechanisms that prevent tumor formation in mammals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells
Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells
Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells
Identifying Conserved Genetic Networks for Eukaryotic MMR Genes
国内基金
海外基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
  • 批准号:
    30840003
  • 项目类别:
    专项基金项目
  • 资助金额:
    12.0万元
  • 批准年份:
    2008
  • 负责人:
    焦宇飞
  • 依托单位: